echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Efficacy of endovascular thrombectomy in patients with acute stroke and cancer

    Neurology: Efficacy of endovascular thrombectomy in patients with acute stroke and cancer

    • Last Update: 2022-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Cancer is a common complication
    in patients with acute ischemic stroke (AIS).
    Multiple retrospective studies have shown that 5-10% of patients with AIS will have known malignancy, with the highest
    risk in the first 6 months after cancer diagnosis or during aggressive chemotherapy.
    For intravenous thrombolysis, national guidelines recommend that altenplase may be reasonable
    in patients with a life expectancy of more than 6 months.
    However, many cancer patients are not eligible for thrombolysis because of the increased incidence of contraindications, such as the simultaneous use of anticoagulation, recent major surgery, brain metastases, or blood system problems such as coagulopathy or thrombocytopenia
    Endovascular thrombectomy (EVT) may be the only possible acute treatment for these patients, but guidelines or clinical studies to guide practice are limited
    A study published in Neurology used a large inpatient database, the National Inpatient Sample (NIS), to examine clinical outcomes
    in cancer patients undergoing EVT.

    During the period 2016-2019, NIS was questioned about admissions to AIS and identified cancer patients
    To compare baseline demographics, comorbidities, reperfusion therapy, and outcomes
    in people with and without cancer with AIS.
    For patients receiving EVT, preference-score matching was used to investigate primary outcomes such as risk of intracranial haemorrhage, length of hospital stay, and discharge management

    The study shows that in modern medical practice, patients with acute stroke complicated with cancer or metastatic cancer have similar rates of intracranial hemorrhage and favorable discharge after endovascular thrombectomy compared with non-cancer patients
    This suggests that patients with AIS who meet the criteria for recanalization may be considered for a combined cancer diagnosis

    Sources: Shapiro SD, Vazquez S, Das A, et al.
    Investigating Outcomes Post Endovascular Thrombectomy in Acute Stroke Patients With Cancer [published online ahead of print, 2022 Sep 19].
    2022; 10.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.